UCSF Medical Center — San Francisco, California

Public research footprint of UCSF Medical Center, compiled from the ClinicalTrials.gov public registry.

605

Registered studies

251

Active

Recruiting now

284

Completed

Stopped or withdrawn

Most-studied conditions

Acute Myeloid Leukemia · Locally Advanced Unresectable Digestive System Neuroendocrine Neoplasm · EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified · Ann Arbor Stage III Lymphocyte-Depleted Classic Hodgkin Lymphoma

Recently updated registry entries

NCT05099003 — A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed… (Recruiting)
NCT04616560 — Trastuzumab Deruxtecan (DS-8201a) for the Treatment of Recurrent or Refractory… (Recruiting)
NCT07174336 — A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at UCSF Medical Center?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 06, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.